Category Specific RSS

Categories: News

Singular Health Group signs MOU and completes equity placement

Medical technology company Singular Health Group rose after it announced the signing of a Memorandum of Understanding (MOU) with Provider Network Solutions (PNS) to collaborate on a technical proof-of-concept and commercial pilot within the PNS Network. Singular Health also announced the completion of a successful equity placement of AUD3.7M at $0.09 per share, including an AUD0.5M cornerstone investment by PNS.

  • Singular Health and Miami-based Managed Service Organisation PNS have signed a MOU for Singular Health’s 3Dicom software.
  • The MOU provides a definitive pathway towards an initial commercial pilot, a subsequent full-scale rollout throughout the PNS network, and a planned National rollout to PNS’ wider network.
  • Singular Health’s Medical File Transfer Protocol (MFTP) enables access to imaging data across disparate PACS networks, regardless of location, resulting in a potential reduction of duplicate imaging costs to payors, risk providers and Managed Service Organisations.
  • Singular Health completes a successful equity placement of AUD3.7M at $0.09 per share, including an AUD0.5M cornerstone investment by PNS.
  • These new funds will be directed towards further development of the 3Dicom software, the MOU implementation and advancement towards a commercial pilot program along with working capital.

PNS is a Miami-based Managed Service Organisation (MSO) with operations in Florida, Texas, and Puerto Rico, managing the provision of healthcare for more than 3.7M Member Plans.

Throughout 2024, Singular Health has, in collaboration with PNS, co-designed a forward workplan and bespoke solution to demonstrate the feasibility of Singular Health’s 3Dicom solution in solving multiple, highly valuable workflows, within PNS’s network to target the reduction in duplicate imaging and improving access to imaging across disparate PACs  systems along with applying analysis to historical and recent images.

Commenting on the PNS MOU, Singular Health’s Managing Director and CEO, Denning Chong said: “We look ahead to the technical proof-of-concept, which is expected to commence in the coming days and to solidify our relationship with PNS in the coming weeks and months. Our focus on providing solutions to MSOs is part of Singular’s scalable business model that would ultimately lead to significant contracts. Our collaboration with PNS during 2024 has given us confidence in our 3Dicom software and its application to other MSOs in the substantial US market.”

Tim Grey

Recent Posts

Control Bionics Moves to Fully Acquire NeuroBounce Program as EMG-Based Performance Tech Gains Momentum

As interest in neuromuscular activation tools accelerates across elite sport, Control Bionics Limited (ASX:CBL) is…

3 days ago

SKS Technologies Moves to Expand NSW Footprint With Delta Elcom Acquisition

Australia’s data-centre construction sector continues to surge on the back of cloud adoption, AI-driven computing…

3 weeks ago

Monash University Partners with HITIQ to Advance Concussion Science Using Smart Mouthguards

A major Australian research initiative is set to push forward global understanding of brain injury,…

4 weeks ago

Harris Technology targets return to profitability amid surging Refurbished Tech sales and Apple expansion

Following a successful FY25 which saw a boost in gross profit after launching its refurbished…

1 month ago

Pivotal Metals Secures $5.4M to Fast-Track Quebec Drill Program

Pivotal Metals (ASX:PVT) has locked in $5.4 million in fresh funding to accelerate exploration across…

1 month ago

Biotron Expands into Anaesthetics with Sedarex Acquisition and $2.5m Raise

Biotech company Biotron Limited (ASX:BIT) has announced a bold step into the anaesthetics sector, acquiring…

2 months ago